Efflux of bile acids in Lactobacillus reuteri is mediated by ATP

Biotechnology Letters

Volumn 33, Issue 11, 2011, Pages 2265-2269

  Bustos, Ana Yanina ^a   Raya, Raúl ^a   de Valdez, Graciela Font ^a,b   Taranto, María Pía ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Active efflux; Bile acid resistance; Lactobacillus

Indexed keywords

ACTIVE EFFLUX; BI-LAYER STRUCTURE; BILE ACID; BILE SALTS; CELLULAR MEMBRANES; CHOLIC ACIDS; ENERGY SOURCE; INTESTINAL BACTERIA; LACTOBACILLUS; LACTOBACILLUS REUTERI; PROTON-MOTIVE FORCES; RESISTANCE MECHANISMS; TOXIC ACTION;

ACID RESISTANCE; CELL MEMBRANES; CYTOLOGY; EXTRUSION; LIPID BILAYERS; SOAPS (DETERGENTS);

BODY FLUIDS;

ADENOSINE TRIPHOSPHATE; CHOLIC ACID; TAUROCHOLIC ACID;

ACTIVE TRANSPORT; ARTICLE; DRUG EFFECT; LACTOBACILLUS REUTERI; METABOLISM;

ADENOSINE TRIPHOSPHATE; BIOLOGICAL TRANSPORT, ACTIVE; CHOLIC ACID; LACTOBACILLUS REUTERI; TAUROCHOLIC ACID;

LACTOBACILLUS; LACTOBACILLUS REUTERI;

EID: 80053180822     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-011-0696-3     Document Type: Article

References (22)

1. Begley M, Gahan CG, Hill C (2005) The interaction between bacteria and bile. FEMS Microbiol Rev 29: 625-651.
2. Bustos AY, Raya R, Bru E, de Valdez GF, Taranto MP (2011) Application of fluorescent techniques to evaluate the survival of probiotic lactobacilli to bile acid. Biotechnol Lett 33: 1389-1394.
3. Elkins CA, Savage DC (2003) CbsT2 from Lactobacillus johnsonii 100-100 is a transport protein of the major facilitator superfamily that facilitates bile acid antiport. J Mol Microbiol Biotechnol 6: 76-87.
4. Florez AB, de Los Reyes-Gavilan CG, Wind A, Mayo B, Margolles A (2006) Ubiquity and diversity of multidrug resistance genes in Lactococcus lactis strains isolated between 1936 and 1995. FEMS Microbiol Lett 263: 21-25.
5. Gueimonde M, Garrigues C, van Sinderen D, de los Reyes-Gavilan CG, Margolles A (2009) Bile-inducible efflux transporter from Bifidobacterium longum NCC2705, conferring bile resistance. Appl Environ Microbiol 75: 3153-3160.
6. Jones ML, Chen H, Ouyang W, Metz T, Prakash S (2004) Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol. J Biomed Biotechnol 2004: 61-69.
7. Kodama K, Hashimoto A, Morita Y, Tomochika K, Tsuchiya T (1998) Preparation and characterization of everted membrane vesicles from cells of Staphylococcus aureus. Biol Pharm Bull 21: 5.
8. Kurdi P, Kawanishi K, Mizutani K, Yokota A (2006) Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol 188: 1979-1986.
9. Lin J, Sahin O, Michel LO, Zhang Q (2003) Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 71: 4250-4259.
10. Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2010) Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 299: G1087.
11. Mazurkiewicz P, Sakamoto K, Poelarends GJ, Konings WN (2005) Multidrug transporters in lactic acid bacteria. Mini Rev Med Chem 5: 173-181.
12. Minahk CJ, Dupuy F, Morero RD (2004) Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J Antimicrob Chemother 53: 240-246.
13. Piddock LJ (2006) Multidrug-resistance efflux pumps-not just for resistance. Nat Rev Microbiol 4: 629-636.
14. Prouty AM, van Velkinburgh JC, Gunn JS (2002) Salmonella enterica serovar typhimurium resistance to bile: identification and characterization of the tolQRA cluster. J Bacteriol 184: 1270-1276.
15. Schmidt EJ et al (2001) Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria. J Antimicrob Chemother 47: 671-674.
16. Taranto MP, Sesma F, Font de Valdez G (1999) Localization and primary characterization of bile salt hydrolase from Lactobacillus reuteri. Biotechnol Lett 21: 935-938.
17. Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF (2000) Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J Dairy Sci 83: 401-403.
18. Taranto MP, Magni C, de Mendoza D, Valdez GF (2001) Kinetics characterization of taurocholic transport in Lactobacillus reuteri. Curr Microbiol 42: 18-20.
19. Taranto MP, Perez-Martinez G, Font de Valdez G (2006) Effect of bile acid on the cell membrane functionality of lactic acid bacteria for oral administration. Res Microbiol 157: 720-725.
20. Thanassi DG, Cheng LW, Nikaido H (1997) Active efflux of bile salts by Escherichia coli. J Bacteriol 179: 2512-2518.
21. Whitehead K, Versalovic J, Roos S, Britton RA (2008) Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Appl Environ Microbiol 74: 1812-1819.
22. Yokota A, Veenstra M, Kurdi P, van Veen HW, Konings WN (2000) Cholate resistance in Lactococcus lactis is mediated by an ATP-dependent multispecific organic anion transporter. J Bacteriol 182: 5196-5201.